Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Claire E. Gates
Observed names:
Claire Gates,
Gates, Claire
Institution:
University of North Carolina at Chapel Hill
Observed institutions:
University of North Carolina at Charlotte,
University of North Carolina at Chapel Hill,
UNC Lineberger Comprehensive Cancer Center
ORCID:
0000-0002-3276-1360
Observed ORCID:
0000-0002-3276-1360
OpenAlex ID:
A5055533877
Making the Enterobacterial Common Antigen Glycan and Measuring Its Substrate Sequestration
2021
·
Colleen R. Eade
, Timothy W. Wallen
, et al.
·
ACS Chemical Biology
·
26
Tirzepatide restricts obesity-related tumor growth by reversing metabolic dysregulation and rescuing CD8+ T cell function
2024
·
Elaine M. Glenny
, Michael F. Coleman
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
16
PDF
General Utilization of Fluorescent Polyisoprenoids with Sugar Selective Phosphoglycosyltransferases
2019
·
Amanda J. Reid
, Beth A. Scarbrough
, et al.
·
Biochemistry
·
15
Unraveling and targeting RAS-driven metabolic signaling for therapeutic gain
2022
·
Jonathan M. DeLiberty
, Ryan Robb
, et al.
·
Advances in cancer research
·
10
Exogenous Metabolic Modulators Improve Response to Carboplatin in Triple-Negative Breast Cancer
2024
·
Alyssa N. Ho
, Violet A. Kiesel
, et al.
·
Cells
·
2
Abstract 2189: Tirzepatide mitigates obesity-associated metabolic dysregulation and tumor progression in a mouse model of triple-negative breast cancer
2024
·
Elaine M. Glenny
, Alyssa N. Ho
, et al.
·
Cancer Research
·
1
Abstract 2188: Tirzepatide treatment restores antitumor immunity in a model of obesity-driven cancer
2024
·
Michael F. Coleman
, Elaine M. Glenny
, et al.
·
Cancer Research
Defining the Role of Mitochondrial Dynamics in Regulating PDAC Cell Sensitivity to KRAS and ERK Inhibition
2023
·
Amber Amparo
, Kristina Drizyte-Miller
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
PDF
Abstract IA26: Exploiting altered metabolism as a therapeutic strategy for RAS-driven cancers
2023
·
Jonathan M. DeLiberty
, Ryan Robb
, et al.
·
Molecular Cancer Research
Abstract B007: Enhancing autophagy inhibition as a therapeutic strategy for pancreatic cancer
2022
·
Jonathan M. DeLiberty
, Ryan Robb
, et al.
·
Cancer Research
Show more works
View as search
Works count:
11
Citation count:
70
H-index:
4
I10-index:
4
Year
Topic
Type
